Association Between Human Papillomavirus Vaccination and Primary Ovarian Insufficiency in a Nationwide Cohort

Overview

Journal JAMA Netw Open

Publisher American Medical Association

Specialty General Medicine

Date 2021 Aug 26

PMID 34436612

Citations 6

Authors

Anders Hviid

Emilia Myrup Thiesson

Affiliations

Soon will be listed here.

Abstract

Importance: Anecdotal case reports have suggested an association between human papillomavirus (HPV) vaccination and primary ovarian insufficiency, but observational studies of HPV and primary ovarian insufficiency are rare, and their findings do not support an association. However, available studies have been limited by statistical power, and concerns about infertility after vaccination are associated with lower levels of uptake of the cancer-preventing vaccine in many countries.

Objective: To evaluate the risk of primary ovarian insufficiency after quadrivalent human papillomavirus (4HPV) vaccination.

Design, Setting, And Participants: This retrospective cohort study with follow-up from 2007 to 2016 used nationwide data for 996 300 Danish-born girls and women aged 11 to 34 years. Cox proportional hazards regression was used to estimate hazard ratios (HRs) of primary ovarian insufficiency diagnoses by 4HPV vaccination status with adjustment for age, calendar period, and a propensity score summarizing health care use. Data were analyzed from October 2020 to January 2021.

Exposures: Receiving 4HPV vaccination compared with receiving no vaccination.

Main Outcomes And Measures: The main outcome was hospital contacts for primary ovarian insufficiency, and the main outcome measures were HRs comparing rates of primary ovarian insufficiency among vaccinated and unvaccinated individuals.

Results: During 6 781 166 person-years of follow-up among 996 300 girls and women aged 11 to 34 years (505 829 vaccinated individuals [50.8%] and 490 471 unvaccinated individuals [49.2%]), 144 individuals were diagnosed with primary ovarian insufficiency, including 54 individuals diagnosed after 4HPV vaccination. The median (interquartile range) age of primary ovarian insufficiency diagnosis was 26.94 (12.68) years. The adjusted HR of primary ovarian insufficiency comparing 4HPV vaccination to no vaccination was 0.96 (95% CI, 0.55-1.68).

Conclusions And Relevance: This study found no association between HPV vaccination and primary ovarian insufficiency. However, given the rarity of the outcome in this study, the presence of a clinically relevant increase in rate of diagnosis cannot be excluded.

Citing Articles

Reply to the Comments on "Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study".

Chen T, Zhang Q, Hung Y, Chang R, Wang S, Cheng-Chung Wei J Drugs. 2024; 84(1):123-125.

PMID: 39133423 DOI: 10.1007/s40265-023-01968-4.

"When you get the HPV vaccine, it will prevent cervical cancer; it will act as a shield": adolescent girls' knowledge and perceptions regarding the human papillomavirus vaccine in Zambia.

Lubeya M, Chibwesha C, Mwanahamuntu M, Mukosha M, Frank S, Kawonga M Front Health Serv. 2023; 3:1208458.

PMID: 37780403 PMC: 10534003. DOI: 10.3389/frhs.2023.1208458.

Association between SARS-CoV-2 vaccination and healthcare contacts for menstrual disturbance and bleeding in women before and after menopause: nationwide, register based cohort study.

Ljung R, Xu Y, Sundstrom A, Leach S, Hallberg E, Bygdell M BMJ. 2023; 381:e074778.

PMID: 37137493 PMC: 10543813. DOI: 10.1136/bmj-2023-074778.

Risk of Premature Ovarian Insufficiency after Human Papilloma Virus Vaccination: A PRISMA Systematic Review and Meta-Analysis of Current Evidence.

Torella M, Marrapodi M, Ronsini C, Ruffolo A, Braga A, Frigerio M Vaccines (Basel). 2023; 11(1).

PMID: 36679985 PMC: 9866915. DOI: 10.3390/vaccines11010140.

Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee.

Taumberger N, Joura E, Arbyn M, Kyrgiou M, Sehouli J, Gultekin M Int J Gynecol Cancer. 2022; 32(10):1316-1320.

PMID: 35820716 PMC: 9554067. DOI: 10.1136/ijgc-2022-003685.

References

Little D, Ward H . Adolescent Premature Ovarian Insufficiency Following Human Papillomavirus Vaccination: A Case Series Seen in General Practice. J Investig Med High Impact Case Rep. 2015; 2(4):2324709614556129. PMC: 4528880. DOI: 10.1177/2324709614556129. View

Christianson M, Wodi P, Talaat K, Halsey N . Primary ovarian insufficiency and human papilloma virus vaccines: a review of the current evidence. Am J Obstet Gynecol. 2019; 222(3):239-244. DOI: 10.1016/j.ajog.2019.08.045. View

Arana J, Harrington T, Cano M, Lewis P, Mba-Jonas A, Rongxia L . Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015. Vaccine. 2018; 36(13):1781-1788. DOI: 10.1016/j.vaccine.2018.02.034. View

Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F . HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccin Immunother. 2019; 15(7-8):1615-1627. PMC: 6783136. DOI: 10.1080/21645515.2018.1564436. View

Schmidt M, Schmidt S, Sandegaard J, Ehrenstein V, Pedersen L, Sorensen H . The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015; 7:449-90. PMC: 4655913. DOI: 10.2147/CLEP.S91125. View

Gruber N, Shoenfeld Y . A link between human papilloma virus vaccination and primary ovarian insufficiency: current analysis. Curr Opin Obstet Gynecol. 2015; 27(4):265-70. DOI: 10.1097/GCO.0000000000000183. View

Pedersen C . The Danish Civil Registration System. Scand J Public Health. 2011; 39(7 Suppl):22-5. DOI: 10.1177/1403494810387965. View

Barboi A, Gibbons C, Axelrod F, Benarroch E, Biaggioni I, Chapleau M . Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society. Clin Auton Res. 2019; 30(1):13-18. DOI: 10.1007/s10286-019-00608-w. View

Naleway A, Mittendorf K, Irving S, Henninger M, Crane B, Smith N . Primary Ovarian Insufficiency and Adolescent Vaccination. Pediatrics. 2018; 142(3). PMC: 6719304. DOI: 10.1542/peds.2018-0943. View

10.

DAgostino Jr R . Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998; 17(19):2265-81. DOI: 10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b. View

11.

Westreich D, Cole S, Funk M, Brookhart M, Sturmer T . The role of the c-statistic in variable selection for propensity score models. Pharmacoepidemiol Drug Saf. 2011; 20(3):317-20. PMC: 3081361. DOI: 10.1002/pds.2074. View

12.

Hawkes D . Evidence evolves over time and should be based on data not opinion. BMJ Evid Based Med. 2019; 25(6):191-192. PMC: 7691699. DOI: 10.1136/bmjebm-2019-111222. View

13.

Little D, Ward H . Ongoing inadequacy of quadrivalent HPV vaccine safety studies. BMJ Evid Based Med. 2019; 25(2):44-45. PMC: 7146940. DOI: 10.1136/bmjebm-2018-111122. View

14.

Lei J, Ploner A, Elfstrom K, Wang J, Roth A, Fang F . HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med. 2020; 383(14):1340-1348. DOI: 10.1056/NEJMoa1917338. View

15.

Colafrancesco S, Perricone C, Tomljenovic L, Shoenfeld Y . Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants. Am J Reprod Immunol. 2013; 70(4):309-16. DOI: 10.1111/aji.12151. View

16.

Grove Krause T, Jakobsen S, Haarh M, Molbak K . The Danish vaccination register. Euro Surveill. 2012; 17(17). DOI: 10.2807/ese.17.17.20155-en. View

17.

Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T . On the association between human papillomavirus vaccine and primary ovarian failure. Am J Reprod Immunol. 2013; 71(4):293-4. DOI: 10.1111/aji.12190. View

18.

Yuan S, Qiu Y, Xu Y, Wang H . Human papillomavirus infection and female infertility: a systematic review and meta-analysis. Reprod Biomed Online. 2020; 40(2):229-237. DOI: 10.1016/j.rbmo.2019.10.019. View

19.

Hawkes D, Buttery J . Human papillomavirus vaccination and primary ovarian insufficiency: an association based on ideology rather than evidence. Curr Opin Obstet Gynecol. 2015; 28(1):70-2. DOI: 10.1097/GCO.0000000000000240. View

20.

Schmuhl N, Mooney K, Zhang X, Cooney L, Conway J, Loconte N . No association between HPV vaccination and infertility in U.S. females 18-33 years old. Vaccine. 2020; 38(24):4038-4043. PMC: 7255493. DOI: 10.1016/j.vaccine.2020.03.035. View